Today: 2 March 2026
Subscribe
Browse Category

Mergers & Acquisitions 25 October 2025 - 4 November 2025

Denny’s Stock Soars on Buyout Bombshell – $620 M Deal, Q3 Misses & What’s Next

Denny’s Stock Soars on Buyout Bombshell – $620 M Deal, Q3 Misses & What’s Next

Denny’s shares surged nearly 46% to $6.20 on Nov. 4, 2025, after announcing a $620 million go-private deal at $6.25 per share. The board approved the all-cash buyout by TriArtisan Capital, Treville Capital, and Yadav Enterprises, with closing expected by Q1 2026. Q3 revenue missed estimates at $113.2 million, and net income fell short at $0.6 million. Same-restaurant sales dropped 2.9% at Denny’s locations.
4 November 2025
···
Kenvue (KVUE) Stock Soars 20% on $48.7 B Buyout News – Q3 Earnings Beat and What’s Next

Kenvue (KVUE) Stock Soars 20% on $48.7 B Buyout News – Q3 Earnings Beat and What’s Next

Kimberly-Clark announced a $48.7 billion cash-and-stock deal to acquire Kenvue, sending Kenvue shares up about 20% in pre-market trading to near $17.50. Kenvue shareholders will receive $3.50 in cash and 0.14625 KMB shares per KVUE share. Kenvue reported Q3 net profit of $398 million, beating earnings expectations. Kimberly-Clark shares fell roughly 12.5% on the news.
3 November 2025
····
Merger Showdown: Union Slams Crédit Agricole–Banco BPM Deal Over Job Cuts and “Deserted” Towns

Merger Showdown: Union Slams Crédit Agricole–Banco BPM Deal Over Job Cuts and “Deserted” Towns

Italy’s First CISL banking union warned that a Banco BPM–Crédit Agricole Italia merger could trigger hundreds of branch closures and heavy job losses, vowing strong opposition. Italian banks closed 268 branches in the first nine months of 2025, accelerating a trend that has left 3,419 towns without a bank. The government said it will set conditions but not block the deal. Banco BPM shares have risen on merger speculation.
3 November 2025
··
Brighthouse Financial (BHF) Stock Soars on Takeover Buzz – Price Jump, Earnings Outlook & Expert Analysis

Brighthouse Financial (BHF) Stock Soars on Takeover Buzz – Price Jump, Earnings Outlook & Expert Analysis

Brighthouse Financial shares soared nearly 27% to around $56 on October 31 after reports of advanced talks to take the insurer private at about $70 per share in a $4 billion deal. The stock had dropped 29% from February to August before takeover speculation reversed losses. Q3 earnings are due November 6, with Wall Street expecting a sharp rebound after a weak Q2. Activist investor Greenlight Capital has pushed for a sale.
31 October 2025
···
Chevron (CVX) Stock Rallies on $2B Pipeline Deal – Could $200 Be Next?

Chevron’s Next Big Move: CVX Stock Could Skyrocket on $55B Hess Deal & Low-Carbon Push

Chevron closed its $55 billion Hess acquisition in July 2025, adding Guyana assets, and sold $2 billion in Colorado pipelines in October. Q3 earnings beat forecasts with adjusted EPS of $1.85 and record production of 4.1 million boe/day. Shares traded at $153–154 on Oct. 31, yielding 4.5%. Analysts’ average 12-month target is $170, with most rating the stock a “Buy.”
31 October 2025
·····
Novo Nordisk (NVO) Stock Tanks as Weight-Loss Empire Faces Boardroom Coup and Fierce Rivalry

Novo Nordisk’s $9B Shock Bid Snatches US Weight-Loss Biotech from Pfizer – Stocks React Big

Novo Nordisk made an unsolicited $8.5 billion bid for Metsera, topping Pfizer’s earlier $7.3 billion deal. Metsera’s board called Novo’s offer “superior,” triggering a four-day window for Pfizer to respond. Metsera shares jumped over 18% on the news, while Novo’s stock fell 3%. Pfizer criticized Novo’s move as “reckless,” warning it could suppress competition.
31 October 2025
····
Activist Investor Shocks Wall Street: $10.9B Comerica Sale Sparks Bank M&A Boom

Activist Investor Shocks Wall Street: $10.9B Comerica Sale Sparks Bank M&A Boom

HoldCo Asset Management took a 1.8% stake in Comerica in mid-2025 and criticized its management, prompting Comerica to agree to a $10.9 billion all-stock sale to Fifth Third Bancorp. The merger will create the ninth-largest U.S. bank with $288 billion in assets. Comerica shares rose 15% on the news, while Fifth Third fell 2%. HoldCo is now pressuring other regional banks for sales or changes.
31 October 2025
···
Rocket Companies Stock Blasts Off After $14B Mega-Merger – Will RKT Keep Soaring?

Rocket Companies (RKT) Stock Soars after $14B Mortgage Mega-Merger and Earnings Beat – What’s Next?

Rocket Companies closed its $14.2 billion all-stock acquisition of Mr. Cooper Group on Oct. 1, the largest mortgage deal on record. Shares traded near $16 on Oct. 30, up about 80% year-to-date despite recent volatility. Q3 earnings beat estimates, with adjusted EPS of $0.07 and revenue of $1.78 billion. The company also agreed to buy Redfin for $1.75 billion earlier in 2025.
30 October 2025
··
Metsera Stock Skyrockets as Pfizer-Novo Clash in $9B Bidding War

Metsera Stock Skyrockets as Pfizer-Novo Clash in $9B Bidding War

Novo Nordisk launched a hostile bid for Metsera on Oct. 30, 2025, offering up to $9 billion and topping Pfizer’s earlier $7.3 billion deal. Metsera shares jumped about 19% in premarket trading. The board called Novo’s offer “superior,” giving Pfizer four days to respond. A law firm began investigating whether the original Pfizer deal was fair to shareholders.
30 October 2025
····
Novo Nordisk (NVO) Stock Tanks as Weight-Loss Empire Faces Boardroom Coup and Fierce Rivalry

Novo Nordisk hijacks Pfizer’s Metsera deal with a $9B bid – obesity-drug war heats up

Novo Nordisk launched an $8.5 billion unsolicited bid for obesity drugmaker Metsera, topping Pfizer’s $7.3 billion agreed deal. Novo’s offer values Metsera at $56.50 per share in cash plus up to $21.25 in milestone payments. Metsera shares jumped 18% premarket, while Novo’s stock fell 3%. Pfizer called Novo’s bid “reckless” and warned it could harm competition.
30 October 2025
····
Alaska-Hawaiian Merger Takes Off: Single Operating Certificate and More

Alaska-Hawaiian Merger Takes Off: Single Operating Certificate and More

The FAA granted Alaska Air Group a single operating certificate for Alaska Airlines and Hawaiian Airlines on Oct. 29, 2025, officially merging their operations. Hawaiian’s callsign and code were retired after HA866 landed in Honolulu, with all flights now using Alaska’s “AS” code. The carriers launched a unified loyalty program, Atmos Rewards, and Alaska announced new Seattle–London and Seattle–Reykjavik routes for 2026.
29 October 2025
···
Pepsi Bottler Goes Boozy: Varun Beverages Surges on Carlsberg Beer Deal & Q3 Profit Jump

Pepsi Bottler Goes Boozy: Varun Beverages Surges on Carlsberg Beer Deal & Q3 Profit Jump

Varun Beverages’ board approved entry into alcoholic drinks, including a distribution deal with Carlsberg to test-market beer in Africa. The company will set up a subsidiary in Kenya and announced a joint venture for refrigeration equipment in India. Q3 net profit rose 19% to ₹741 crore despite flat domestic sales. Shares surged up to 10% on October 29, rebounding after recent declines.
29 October 2025
··
Cygnet’s $1.4 B Oil Patch Power Play – Kiwetinohk Shareholders Score Big Premium in Alberta Energy Deal

Cygnet’s $1.4 B Oil Patch Power Play – Kiwetinohk Shareholders Score Big Premium in Alberta Energy Deal

Cygnet Energy will acquire Calgary-based Kiwetinohk Energy in an all-cash deal valued at C$1.4 billion, including debt. Kiwetinohk shareholders will receive C$24.75 per share, about 10% above the last closing price. The combined company will produce over 44,000 barrels of oil equivalent per day. The transaction is expected to close by late December 2025, pending approvals.
28 October 2025
···
Huntington Bancshares’ Bold Moves: Strong Earnings and a $7.4B Bank Takeover Shake Up HBAN Stock

Huntington Bancshares’ Bold Moves: Strong Earnings and a $7.4B Bank Takeover Shake Up HBAN Stock

Huntington Bancshares reported Q3 net income of $629 million, up 22% year-over-year, beating forecasts. The bank announced a $7.4 billion all-stock acquisition of Cadence Bank, expanding into Texas and the Southeast. HBAN shares fell 3–4% pre-market after the merger news, trading around $15. Shares remain about 15% below their 52-week high.
27 October 2025
··
American Water & Essential Utilities to Merge in $63B ‘Mega-Deal’ – What Investors Need to Know

American Water & Essential Utilities to Merge in $63B ‘Mega-Deal’ – What Investors Need to Know

American Water Works and Essential Utilities boards approved an all-stock merger on Oct. 26, 2025, creating a $40 billion utility serving 4.7 million connections in 17 states. The combined company will keep the American Water name and be led by AWK’s John C. Griffith as CEO. Essential shareholders receive a 10% premium; AWK holders will own 69% of the new firm. No immediate rate hikes are planned. The deal is expected to close by Q1 2027.
27 October 2025
···
Huntington’s $7.4B Texas-Tupelo Power Move: Cadence Bank Takeover Shakes Up Banking

Huntington’s $7.4B Texas-Tupelo Power Move: Cadence Bank Takeover Shakes Up Banking

Huntington Bancshares agreed to acquire Cadence Bank in an all-stock deal valued at $7.4 billion, giving Cadence shareholders 2.475 HBAN shares per Cadence share. The combined bank will hold $276 billion in assets and $220 billion in deposits, becoming a top-10 U.S. regional bank. The merger is expected to close in Q1 2026 pending approvals. Huntington shares fell 3–4% pre-market, while Cadence rose about 2%.
27 October 2025
··
RNA Stock Skyrockets: Avidity Biosciences Soars on $12B Novartis Buyout and Breakthrough Trials

RNA Stock Skyrockets: Avidity Biosciences Soars on $12B Novartis Buyout and Breakthrough Trials

Novartis will acquire Avidity Biosciences for $72 per share in cash, a deal valuing Avidity at $12 billion and marking a 46% premium over its last close. The transaction, announced Oct. 26, 2025, is expected to close in the first half of 2026. Before closing, Avidity will spin off its early-stage cardiology programs into a new company, with shareholders receiving both cash and SpinCo shares.
27 October 2025
·····
Novartis’ $12B Biotech Buyout Shakes Up Avidity Biosciences (RNA) – Is the Rare-Disease Stock Set to Soar?

Novartis’ $12B Biotech Buyout Shakes Up Avidity Biosciences (RNA) – Is the Rare-Disease Stock Set to Soar?

Novartis will acquire Avidity Biosciences for $12 billion in cash, offering $72 per share—a 46% premium over Avidity’s last close. Avidity’s stock, which ended Friday at $49.15, is expected to jump sharply when markets open. Novartis is targeting Avidity’s RNA therapies for rare muscle diseases, including a lead drug nearing FDA submission. The deal was announced Sunday, Oct. 26, 2025.
26 October 2025
····
1 … 15 16 17 18 19 20
Go toTop